Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SEVELAMER for Hyperparathyroidism: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where SEVELAMER was used for Hyperparathyroidism.

Most Reported Side Effects for SEVELAMER

Side Effect Reports % Deaths Hosp.
Constipation 2,041 35.7% 1 32
Pruritus 772 13.5% 0 10
Diarrhoea 665 11.6% 8 31
Nausea 484 8.5% 5 37
Vomiting 300 5.3% 4 34
Flatulence 217 3.8% 0 9
Abdominal pain 193 3.4% 6 45
Death 170 3.0% 167 13
Crystal deposit intestine 168 2.9% 9 79
Dyspepsia 141 2.5% 0 0
Hyperphosphataemia 129 2.3% 1 10
Colitis 113 2.0% 2 58
Hospitalisation 106 1.9% 12 105
Overdose 101 1.8% 3 3
Drug ineffective 85 1.5% 6 21

Other Indications for SEVELAMER

Product used for unknown indication (2,966) Hyperphosphataemia (533) Chronic kidney disease (187) End stage renal disease (176) Blood phosphorus increased (47) Blood phosphorus (25) Blood phosphorus abnormal (25) Dialysis (20) Renal failure (18) Renal failure chronic (18)

Other Drugs Used for Hyperparathyroidism

CINACALCET (704) DENOSUMAB (97) CALCIFEDIOL (49) ETELCALCETIDE (40) PARICALCITOL (38) CALCITRIOL (23) ALFACALCIDOL (17) DOXERCALCIFEROL (15) CALCIUM (14) HECTOROL (14)

Related Pages

SEVELAMER Full Profile All Hyperparathyroidism Drugs SEVELAMER Demographics SEVELAMER Timeline